SV40 is a small virus but in its approximately 5200 base pairs is enough information either to productively grow in a permissive cell, or to convert a normal cell into a transformed one. The conversion is usually genetically stable enough to generate clonable lines of transformed cells. Some of these lines lose so much of their normal growth control that they acquire the capacity to grow as tumors. Since the total DNA sequence of SV40 is known, it is somewhat surprising that the mechanism of action of SV40 in maintaining the various transformed state in vitro is not at all well understood. Also, and probably not coincidentally, precisely which SV40-encoded molecules are necessary for maintenance of any of these states is an unsettled issue as well. The first question cannot be easily asked without a study of the second. Yet, few single laboratories have the capacity to ask both in a careful way. We propose here to ask both, through an interacting set of six separate collaborative projects directed at the sequence-protein-function relationships of the SV40 transforming genes. We will initially test the hypothesis that variant non-lytic forms of large T are essential for full expression of the transformed phenotype. 1. Directed deletion of SV40 DNA and analysis of lytic function. 2. Mapping and recovering SV40 from within transformed cells. 3. Transfection/transformation with novel SV40 DNA sequences. 4. T antigen: properties and activities of variant lytic and transformed cells. 5. Directed methylation of SV40 DNA analysis of methylation. 6. SV40 RNA processing (oocyte).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA033620-04
Application #
3093518
Study Section
Cancer Special Program Advisory Committee (CAK)
Project Start
1983-06-01
Project End
1987-11-30
Budget Start
1986-06-01
Budget End
1987-11-30
Support Year
4
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
Graduate Schools
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10027
Friedman, P N; Chen, X; Bargonetti, J et al. (1993) The p53 protein is an unusually shaped tetramer that binds directly to DNA. Proc Natl Acad Sci U S A 90:3319-23
Bargonetti, J; Manfredi, J J; Chen, X et al. (1993) A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. Genes Dev 7:2565-74
Prives, C (1993) Doing the right thing: feedback control and p53. Curr Opin Cell Biol 5:214-8
Harper, J E; Manley, J L (1992) Multiple activities of the human splicing factor ASF. Gene Expr 2:19-29
Friedman, P N; Wang, E H; Meerovitch, K et al. (1992) Murine p53 inhibits the function but not the formation of SV40 T antigen hexamers and stimulates T antigen RNA helicase activity. Chromosoma 102:S60-6
Bargonetti, J; Reynisdottir, I; Friedman, P N et al. (1992) Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes Dev 6:1886-98
Huber, P W; Morii, T; Mei, H Y et al. (1991) Structural polymorphism in the major groove of a 5S RNA gene complements the zinc finger domains of transcription factor IIIA. Proc Natl Acad Sci U S A 88:10801-5
Bargonetti, J; Friedman, P N; Kern, S E et al. (1991) Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication. Cell 65:1083-91
Fukasawa, K; Sakoulas, G; Pollack, R E et al. (1991) Excess wild-type p53 blocks initiation and maintenance of simian virus 40 transformation. Mol Cell Biol 11:3472-83
Prives, C; Bargonetti, J; Friedman, P N et al. (1991) Functional consequences of the interactions of the p53 tumor suppressor protein and SV40 large tumor antigen. Cold Spring Harb Symp Quant Biol 56:227-35

Showing the most recent 10 out of 40 publications